The water extract from the red marine alga Polysiphonia denudata (Dillwyn) Kiitz. from the Bulgarian Black Sea coast selectively inhibited the reproduction of herpes virus type 1 and type 2 in cell cultures (EC50 = 8.7 to 47.7 mg/ml) as shown by the reduction of virusinduced cytopathic effect and viral infectivity. The virus-inhibitory effect was dose-related, strain-specific and depended on virus inoculum. The inhibition affected adsorption as well as the intracellular stages of viral replication. The presence of the extract throughout the whole replicative cycle was necessary for the full expression of the antiviral effect. In higher concentrations (M IC90 = 6.5 mg/ml) the extract exhibited strong extracellular virus inactiva ting activity.
Introduction
Acute and recurrent herpes simplex virus (HSV) infections are still a problem. The search for selective antiviral agents has been vigorous in recent years but the need for new antiviral thera pies still exists. Recent biochemical and pharma ceutical investigations on marine algae evaluate them as an interesting source of potential antiviral compounds (Che, 1991; Kerr and Kerr, 1999) . As a part of a project on the antiinfective activities of marine organisms we evaluated the antiinfluenza virus activity of 70 products. 20% showed signifi cant antiviral effect (Serkedjieva et al., 2000) . Most effective was the water extract of the red marine alga Polysiphonia denudata, var. Fragiris, endemic at the Bulgarian Black Sea sea coast. It inhibited selectively the reproduction of influenza virus in cell cultures and in fertile hen's eggs and protected mice against experimental influenza infection.
The present study was undertaken to evaluate the antiherpes virus effect of the preparation in cell cultures with respect to the selectivity and specificity of inhibition.
Materials and Methods

Plant material and extraction
The alga Polysiphonia denudata (Dillwyn) Kiitz. (Rhodophyta -Florideophyceae) was collected along the South Bulgarian sea coast of the Black Sea near the Varvara village in summer at a depth of 2-10 m. The fresh organism was cleaned of epi phytes and dead parts, washed with fresh water, dipped in ethanol and transported to the labora tory. The alga was identified by Dr. Stefka Dimit rova -Konaklieva, Faculty of Pharmacy, Medical University, Sofia. About 100-120 g of the fresh material, corresponding to 10-15 g of dry mate rial, was homogenized with chloroform -metha nol (500 ml, 1:1, v/v) and refluxed for a few to inactivate the enzymes. The extraction was re peated three times, the combined extracts were concentrated to about 200 ml and water (200 ml) was added. Two layers were formed, the upper one -water -contained polar compounds. In the upper phase there was about 2-3 g material. It was evaporated to dryness (Polysiphonia extract). The Polysiphonia extract was prepared and kindly provided by Dr. Monika Konaklieva, Institute of Organic Chemistry with Centre of Phytochemistry, Bulg. Acad. Sei. For the antiviral experiments a 10% stock solution of the preparation was made with distilled sterile water and the subsequent working dilutions were made with cell culture me dium ex tempore.
Cell cultures and media
Permanent cell lines from African green mon key kidney (Vero) cells (from the Institute of Antiviral Chemotherapy, Erfurt, Germany) and human embryonic skin-muscle (E6SM) cells (from the Rega Institute of Antiviral Research, Leuven, 0939-5075/2000/0900-0830 $ 06.00 © 2000 Verlag der Zeitschrift für Naturforschung. Tübingen • www.znaturforsch.com • N Belgium) were cultivated in Eagle's minimal essential medium (MEM) (Sigma-Aldrich GmbH, Deisenhofen, Germany), supplemented with 10% foetal calf serum (FCS) and antibiotics (benzylpenicillin-100 IU/ml and streptomycin-100 |ig/ml) and L-glutamine (growth medium) at 37 °C in the presence of 5% C 0 2 till the formation of confluent monolayers. In cell toxicity and antiviral experi ments 1.5% FCS was added to M EM (mainte nance medium).
Viruses
Herpes simplex virus type 1 (HSV-1), strain Kupka was from the collection of the Institute of Antiviral Chemotherapy, Erfurt, Germany. The virus was propagated in Vero cells. The experi ments with this virus were performed in the labo ratory of Prof. R. Klocking in the same institute.
HSV-1, strain KOS and HSV type 2 (HSV-2), str. GC25927 were from the collection of the Rega Institute of Antiviral Research, Leuven, Belgium. The viruses were propagated in E6SM cells. The experiments with these viruses were performed in the laboratory of Prof. E. De Clercq in the same institute.
Cell toxicity
Cell toxicity was monitored by determining the effect of the preparations on cell morphology and viability. The cytopathic effect (CPE) was scored on day 2-7 of incubation as described in Ser kedjieva and Hay (1998). The concentration re quired to cause visible changes in 50% of intact cells, 50% toxic concentration (TC50), was esti mated from graphic plots. The cytotoxicity for Vero cells was determined also by a colorimetric method based on the reduction of the tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-dyphenyltetrazolium by viable cells (MTT assay) (Mosmann, 1983) . The optical density (O D 540690) was deter mined by an Anthos Microplate Reader. The per centage of viable treated cells was calculated in relation to untreated controls (% of cell control = O D exp/O D cell c o n t r o l X 100). TC50 was the concen tration required to reduce the O D by 50%.
Virucidal activity
The direct virus inactivating effect of the prepa ration was tested in the contact assay as described before (Serkedjieva and Hay, 1998) . The minimal concentration required to reduce the infectious titre, expressed in 50% tissue culture infectious doses per ml (TCID50/ml) by 1 log10 (by 90%) was estimated from graphic plots (M IC90).
A ntiviral assays
The virus-inhibitory effect of the preparation was studied by:
1. Cytopathic effect reduction assay (C P E R). Quadruplicate confluent monolayers in 96-well plates were overlaid with serial two-fold drug-con taining medium (0.05 ml) and equal volume of virus suspension (102-104 TCID50/ml). The virus induced CPE was scored on day 3-4 post infection (p.i.) for E6SM and on day 5-7 p.i. for Vero by an inverted microscope as described by Serkedjieva and Hay (1998) . The reduction of virus multiplica tion was calculated as % of virus control (% virus control = CPEexp/CPEvirus control x 100). The con centration reducing CPE by 50% in respect to virus control was defined as 50% effective concen tration (EC50) and was estimated from graphic plots. The selectivity index (SI) was calculated from the ratio TC5o/EC5o.
Infectious virus yield reduction assay (IV Y R )
. This was performed after Serkedjieva and Hay (1998) . The concentrations that reduced virus infectivity by 90% (1 log10TCID50/ml; EC90) was de termined.
3. MTT assay. We used a modification of an MTT-assay developed for screening of anti-HSV compounds by Takeuchi et al. (1991) . In short, quadruplicate confluent monolayers in 96-well plates were overlaid with serial two-fold drug-con taining medium (0.05 ml) and an equal volume of virus suspension (102-104 TCID50/ml). On day 7 p.i. the supernatants were discarded and 20 (il of MTT, 5 mg/ml in PBS, was added to each well; the monolayers were incubated for 3-6 h at 37 °C. The resulting formazan precipitate was dissolved in iso-propanol with the addition of DM SO and the O D were determined at 492 nm (test) and 690 nm (reference). The % of protection was calcu lated by the following formula dicate the absorbancies of the test sample, the virus control and the cell control, respectively. The EC50 was estimated from graphic plots as the con centration achieving 50% protection of infected cells according to the above formula. The SI for each compound was determined as described above.
4. E Z 4 U assay. The assay was performed with a commercial kit from Biomedica GmbH, Germany. It is an improved and simplified version of the MTT assay, on the base of another tetrazolium salt -2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydrox ide (XTT). The experiments were performed as described above, there was no need of organic solvent as the precipitate was water-soluble, the absorbancies were read at wavelengths 450 and 620 nm (O D 450 620). % of protection, EC50 and SI were estimated as described above.
Timing o f addition studies
Confluent monolayers were incubated with plain or drug-containing medium for 1 h (effect of cell pre-treatment), washed twice with PBS and challenged with serial ten-fold dilutions of infec tious virus. Adsorption was carried out for 1 h at 4 °C to prevent virus internalisation in the pres ence or in the absence of 2x drug-containing me dium (effect on adsorption). The cells were washed twice with PBS and overlaid with plain or drug-containing medium for 1 h to allow viral par ticles to penetrate into cells (effect on penetra tion). Then plain or drug-containing medium was added and cells were cultivated for 24 h at 37 °C (effect on replication). At the end of cultivation the cells were frozen and after one freeze-thaw cycle infectious titres were determined. A viral titre reduction by 1 log10TCID50/ml (90%) was considered to indicate a significant antiviral effect. The significance of the difference in infectious titres was estimated (Student's /-test).
Drug-susceptibility testing
The inhibition of virus replication, followed by CPER assay was used to determine the inhibitory effect of the extract on selected HSV strains.
In all antiviral experiments non-drug treated, mock-infected cells were used as cell control and non-drug treated, virus-infected cells -as virus control. The selective inhibitor of HSV repro duction (£')-5-(2-bromovinyl)-2'-deoxyuridine (Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany) was used as a positive control.
Results
Cell toxic activity of Polysiphonia extract was monitored by two different assays -morphologi cal (CPE) and colorimetric (MTT). The results for both assays were similar and the effect was doserelated (Table I ). As a first experimental approach for the evalua tion of the antiviral activity of the preparation we studied its ability to produce a direct inactivating effect on extracellular virus. The results are pre sented in Fig. 1 . In concentrations <2 mg/ml the extract did not show any virucidal activity. The ef fect was dose-dependent. M IC 90 was 6.5 mg/ml.
Polysiphonia extract inhibited significantly the reproduction of a range of herpes simplex type 1 and type 2 viruses in cell cultures (Table I, Fig. 2 ). The inhibitory effect was selective, strain-specific and dose-dependent; selectivity indices ranged from 0.18 to 1.2. Virus inhibition depended also on virus inoculum (data not shown). The suscep tibility of three different strains to Polysiphonia extract was compared in the CPER assay. The re sults are presented in Fig. 2 . Most susceptible was HSV-1, str. Kupka (SI = 47.7). There were ob-Polysiphonia extract (mg/ml) Fig. 1 . Virus-inactivating effect of Polysiphonia extract on HSV-1, str. KOS. Polysiphonia extract (mg/ml) Fig. 2 . Drug-susceptibility of HSV-1 and HSV-2 viruses to Polysiphonia extract inhibition.
served differences in the degree of viral inhibition depending on the assay used. Though the number of tested viruses was limited the observed strainspecificity of inhibition was indicative of selective antiviral action. Polysiphonia extract inhibited significantly the reproduction of HSV-1, str.
McIntyre in Vero with doses >0.23 mg/ml (Table I ). In the IV Y R assay at 24 h of incubation with 0.4 and 0.8 mg/ml of the extract no infectious virus was detected; however at 48 h after infection a great reduction of infectivity was observed (01og10TCID50/ml = 2.8-3.2).
To examine the effect of the Polysiphonia ex tract on different steps of viral replication the preparation was added at varying times relative to viral infection. The results are presented in Ta ble II. The pre-treatment of cells (A) with 1 mg/ ml of the extract as well as the addition at the time of penetration (C) did not reduce virus infectivity. Virus replication was considerably reduced when the extract was added at the time of adsorption (B) and when the preparation was inoculated after viral infection (D) -01og10TCID50/ml = 2.39. (Rinehart, 1989) . The marine organisms represent also a promising source of antiviral compounds (for re view see Che, 1991; Kerr and Kerr, 1999) . A number of studies have been reported on the in hibitory effects of algal extracts and isolated bio logically active constituents on the replication of herpes simplex viruses. Deig et al. (1974) reported that aqueous extracts from Farloxvia mollis and Cryptosiphonia woodii interfered significantly with HSV-1 reproduction. Ehresmann et al. (1977) studied the virus-inhibitory activity of 28 extracts from marine algae; ten species of Rhodophyta contained substances which caused marked reduc tion of HSV-1 infectivity. Andersson et al. (1983) examined extracts from 25 marine organisms col lected along the Swedish coast for biological activ ities, including the plaque formation with HSV-1. The chloroform extract from Fucus seratus and pe troleum ether extract from Lam inaria digitata ex hibited suppressive effects at concentrations of 100 |Ag/ml without showing toxicity. Girre et al. (1987) reported that a water extract from the marine alga Ascophyllum nodosum inhibited the replication of HSV-1. Hayashi et al. (1996) assayed 49 extracts from algae for anti-HSV and anti-HIV activities. Twenty five aqueous extracts showed anti-HSV ac tivity, four of which were most potent inhibitors.
The herpes virus inhibitory effect of the water extract from Polysiphonia denudata was evaluated against the reproduction of HSV-1 and HSV-2 strains in two lines of cell cultures by a number of different assays. Virus-induced cytopathic effect and infectious virus yields were reduced at non toxic concentrations of the extract. High concen trations of the preparation (> 10 mg/ml) exhibited a strong inactivating effect on extracellular virus. The virus-inhibitory effect however could not be explained with the direct virucidal activity alone as MICcx) was 9.6 mg/ml while EC50 was 0.42 mg/ ml. The selectivity of antiviral action was con firmed by the variation in sensitivity of different herpes viruses to Polysiphonia extract.
To investigate on the specificity of the inhibitory effect the preparation was tested for inhibitory ac tion on the reproduction of poliovirus 1, str. Mahony in FL (Fogh-Lund human amniotic cell line) cell cultures and no reduction of infectivity was observed (unpubl.). The extract did not reduce the growth of Staphylococcus aureus and Escherichia coli . Thus the virus-inhibitory effect seemed to be selective and specific.
Although adsorption was recognised as one of the targets of virus inhibition, the effect was di rected also against some intracellular stages of viral replication; the process directly affected was not identified. At this stage of our investigations we can not discuss in detail the mechanism of the inhibitory effect of the water extract from Polysi phonia denudata. Ehresmann et al. (1977) and Richards et al. (1978) suggested that herpes virus inhibition by algal extracts was due to a block at 834 viral adsorption. Al algal extract inhibited HSV-1 penetration into cells but did not inhibit virus attachment (Hayashi et a l, 1993) . Virus-specific protein synthesis in HeLa cells was inhibited selec tively as well (Hayashi et a l, 1993) . The Polysipho nia extract reduced significantly the reproduction of influenza virus in cell cultures; an inhibition of adsorption and reduction of viral antigen expres sion on the surface of infected cells was observed (unpubl.). In connection with the presumed inter ference of the preparation with the early steps of viral replication -adsorption, fusion and/or en try -it would be interesting to study the interac tion between the Polysiphonia extract and the her pes virus glycoproteins.
The dry Polysiphonia extract was fractionated with solvents with increasing polarity -petroleum ether, dichlorethane, ethyl acetate, butanol and water. Only the ethyl acetate fraction exhibited a significant antiviral effect. At this stage of investi gation we cannot define the biologically active components of the preparation. However the cur rent results support the view that marine organ isms present an interesting source of potential antiviral compounds (Che, 1991; Kerr and Kerr, 1999) .
